ArticleOncotarget2021

Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplication.

Mario Scarpa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.